BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
批准号:
10357023
负责人:
Hamid Ghandehari
金额:
$48.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-09-28 至 2026-11-30
关键词:
AcuteAddressAdsorptionAdverse effectsAffectAnimal ModelAnimalsAntibodiesApplications GrantsBacteriaBiodistributionBiologicalBloodBone MarrowCell CycleCell divisionCessation of lifeCharacteristicsChronicCuesDependenceDoseDrug CarriersDrug Delivery SystemsExposure toFemaleFrequenciesGene ExpressionGenerationsGenesGenetic TranscriptionGeometryHealthHormonesHumanImmuneImmune responseImmune signalingImmune systemImmunoglobulin GImmunoglobulin MImmunologicsIn VitroInbred BALB C MiceInflammasomeInflammatory ResponseInjectionsIntravenousInvestigationKnowledgeLeadLeukocytesLiverLiver ExtractLungLymphocyteMaximum Tolerated DoseMediatingMetabolic Clearance RateMetabolismModificationMolecularMononuclearMusOrganPhagocytesPhenotypePluripotent Bone Marrow Stem CellPorosityPropertyProteinsRattusRecoverySafetySignal PathwaySignal TransductionSilicon DioxideSpleenSurfaceSystemTestingTimeTissuesToxic effectVacuoleVariantWhole Bloodbasebiomaterial compatibilitycytotoxicitydensitygenotoxicitygranulocyteimmune functionimmunotoxicityin vivoinnovationmacrophagemalemonocytenanoparticleneutrophiloverexpressionparticlepatient populationperipheral bloodresponsesexside effectuptake
中文摘要
项目总结
全身给药二氧化硅纳米粒(SNPs)的一个主要挑战是通过和
在单核吞噬系统(MPS)器官中的蓄积,以及随后的免疫反应。穷
SNPs的载量,它们在巨噬细胞中的稳定性和空泡化,以及潜在的低代谢和
患者人群的清除率可能需要使用高剂量和频繁剂量的SNPs,
可能会导致MPS饱和和过载。MPS中SNPs免疫毒性的详细研究
需要建立他们的安全概况,以选择具有明确免疫学特性的药物载体。这个
SNPs对吞噬细胞摄取和饱和后命运和功能的影响及对宿主免疫的影响
对此的反应需要进一步阐明。单核苷酸多态的理化性质与遗传易感性的相关性
性别依赖性毒性的机制尚不清楚。同时观察静脉注射后免疫反应的变化。行政管理
SNPs的数量以及这种反应背后的机制在很大程度上是未知的。要解决这些知识差距,
这项赠款申请的具体目的如下:
1)研究SNPs饱和对巨噬细胞吞噬功能的影响。
存活、增殖和免疫信号作为纳米颗粒物理化学性质的函数。这个
在这一目标中需要检验的基本假设是,SNPs对巨噬细胞的饱和将影响其
基于纳米颗粒特性的正常功能、分子信号和命运。
2)研究静脉注射后组织驻留巨噬细胞的骨髓毒性和功能。
给予SNPs,并评估体外循环吞噬细胞的数量和激活状态
暴露于SNPs。在这一目标中要检验的基本假设是,
SNPs影响骨髓、组织驻留巨噬细胞和外周血的正常功能
吞噬细胞,这一现象可能是可逆的,取决于给药的剂量和频率。
3)研究全身应用SNPs AS的免疫副作用和抗聚乙二醇反应。
动物性别和颗粒物理化学性质的函数。基本的假设是:i)反聚乙二醇化
免疫球蛋白和免疫球蛋白将在接触聚乙二醇单核苷酸的情况下以时间依赖的方式产生;ii)在
雌性与雄性Th1和Th2偏向动物模型的免疫反应将有助于SNP的毒性和免疫-
间接的副作用。
这一建议具有重要意义,因为对SNP的关键物理化学性质有很好的了解-
明确的免疫学特性将有助于建立更安全的静脉给药平台。它是创新的
因为它第一次接近不同的SNP与免疫系统的不同组件的相互作用
由于动物的性别和免疫系统的不同而产生偏差。
英文摘要
PROJECT SUMMARY
A major challenge with systemic administration of silica nanoparticles (SNPs) is clearance by and
accumulation in organs of mononuclear phagocytic system (MPS), and subsequent immune response. Poor
loading capacity of SNPs, their stability and vacuolization in macrophages, and potentially lower metabolism and
clearance rates in patient populations may necessitate administration of high and frequent doses of SNPs which
could lead to MPS saturation and overload. Detailed investigation of immunotoxicity of SNPs in the MPS is
needed to establish their safety profile to choose drug carriers with well-defined immunological properties. The
influence of SNPs on the fate and function of phagocytes after uptake and saturation, and on host immune
response need further elucidation. The correlation between the physicochemical properties of SNPs and the
mechanisms of sex-dependent toxicity is unclear. Also, the immune response alteration upon i.v. administration
of SNPs and the mechanisms behind this response are largely unknown. To address these knowledge gaps in
this grant application the following Specific Aims are proposed:
1) To investigate the influence of saturation of macrophages with SNPs on their phagocytic activity,
survival, proliferation, and immune signaling as a function of nanoparticle physicochemical properties. The
underlying hypothesis to be tested in this aim is that saturation of macrophages by SNPs will influence their
normal function, molecular signaling, and fate based on nanoparticle characteristics.
2) To investigate bone marrow toxicity and function of tissue-resident macrophages after i.v.
administration of SNPs, and assess the number and activation status of circulating phagocytes after in vitro
exposure to SNPs. The underlying hypothesis to be tested in this aim is that size, geometry, and porosity of
SNPs influence the normal function of bone marrow, tissue-resident macrophages, and peripheral blood
phagocytes, a phenomenon which may be reversible and depend on dose and frequency of administration.
3) To investigate the immune side effects and anti-PEG response of systemically administered SNPs as
a function of animal sex and particle physicochemical properties. The underlying hypotheses are: i) Anti-PEG
IgM and IgG will be generated in a time-dependent manner upon exposure to PEGylated SNPs; ii) variation in
immune response in female vs male Th1 and Th2 bias animal models will contribute to SNP toxicity and immune-
mediated side effects.
This proposal is significant because understanding key physicochemical properties of SNPs with well-
defined immunological properties will help establish safer platforms for intravenous drug delivery. It is innovative
because for the first time it approaches different SNP interactions with various components of the immune system
as a result of animal-sex and different immune-biased in a systematic fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10296670
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10530585
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
-
批准号:10058818
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2018
-
负责人:Hamid Ghandehari
-
依托单位:
In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
-
批准号:8314876
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:Hamid Ghandehari
-
依托单位:
Targeted Polymeric Combination Delivery for Treatment of Ovarian Cancer
-
批准号:7999063
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7615449
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7916398
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7627049
-
项目类别:
-
资助金额:$31.34万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7633399
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7341354
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7848308
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological Fate and Biocompatability of Dendritic and Silica-Based Nanoconstructs
-
批准号:8761265
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS
-
批准号:10579946
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Dendritic Biomaterials for Oral Delivery of Chemotherapeutics
-
批准号:7487476
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological Fate and Biocompatability of Dendritic and Silica-Based Nanoconstructs
-
批准号:8918618
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7676202
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Biological fate and biocompatibility of dendritic and silica-based nanoconstructs
-
批准号:7501972
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2007
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7142801
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7658258
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
Polymers for Targeted Delivery of Angiogenic Inhibitors
-
批准号:7434460
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2006
-
负责人:Hamid Ghandehari
-
依托单位:
海外基金